Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:NBIX
Tag: NASDAQ:NBIX
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Tourette’s Syndrome Trial Flops
-
May 25, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
May 24, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 9, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Entry into a Material...
ME Staff 8-k
-
May 2, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Entry into a Material...
ME Staff 8-k
-
April 25, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Other Events
ME Staff 8-k
-
April 12, 2017
0
Phase 2b Trial Demonstrates Positive Results For AbbVie Inc (NYSE:ABBV) Elagolix
-
April 10, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Other Events
ME Staff 8-k
-
March 13, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Results of Operations and...
ME Staff 8-k
-
February 15, 2017
0
NEUROCRINE BIOSCIENCES, INC. (NASDAQ:NBIX) Files An 8-K Entry into a Material...
ME Staff 8-k
-
February 12, 2017
0
1
2
3
4
Page 3 of 4
